Tuesday, November 17, 2026

Christina Applegate Investigates Link Between Implants and Chronic Pain

Share

Christina Applegate, 54, an actress, is currently investigating a potential connection between her breast implants and the chronic pain and fatigue she has been experiencing. This inquiry follows her recent revelation of being misdiagnosed with multiple sclerosis (MS) in 2021.

During the November 10 episode of MeSsy, a podcast she co-hosts with Jamie-Lynn Sigler, Applegate, who rose to fame as a teenager on the popular sitcom Married With Children, shared that she received a study claiming that symptoms related to breast implants could mimic those of MS.

“Honestly, for the past five years, I’ve wondered, ‘What if they’re leaking and causing me harm?'” she mentioned, stating her intention to consult with her healthcare providers about this possibility.

In 2008, Applegate underwent a double mastectomy and breast reconstruction after being diagnosed with an early stage of breast cancer and testing positive for a BRCA1 gene mutation, which increases the risk of breast and other types of cancers. On her podcast, she expressed that she was “well overdue” for replacing her implants.

She has also reported increasing pain and struggles with mobility in her right shoulder, mentioning it can take her at least 10 minutes to sit up and get out of bed. The variety of symptoms, she noted, is overwhelming due to the “many different things that could be happening.”

Her exploration into this matter comes after doctors informed her in October that she does not have MS. Following this news, Applegate stated she felt like she was back at “Square 1,” and while enduring ongoing physical challenges, she is undergoing tests to investigate other possible conditions, such as rheumatoid arthritis, lupus, and Lyme disease.

Although the cause of her symptoms remains unclear, breast implants have been associated with certain illnesses in some instances, though the nature of this connection is not fully understood.

Understanding Breast Implant Illness

As connections between breast implants and autoimmune diseases become clearer, women with breast implant illness urge doctors to warn others of the risks. Unknown hands hold a Biocell textured breast implant by Allergan.

Breast implant illness, or BII, encompasses symptoms reported by some individuals with implants, such as fatigue, cognitive changes, joint pain, and muscle pain. The image shows a Biocell textured breast implant by Allergan. (Nicolas Amaya/CBC)

Breast implant illness, abbreviated as BII, refers to a range of symptoms experienced by certain individuals with implants.

As of December 31, 2025, Health Canada reported receiving 663 accounts of symptoms or conditions linked to breast implants, which equates to about one report for every 1,025 implants sold in the country.

Fatigue was the most commonly reported issue, followed by mood alterations, gastrointestinal symptoms, and cognitive changes. It is important to note that these are reports and not confirmed diagnoses; Health Canada states that the existing information cannot definitively determine whether implants are the cause of these symptoms, as other factors may be involved.

The U.S. Food and Drug Administration (FDA) indicates that BII is not recognized as an official medical diagnosis and lacks a specific testing protocol. Reports of issues like fatigue and joint pain do not clarify the frequency of these occurrences or confirm if implants are the cause.

Julie Elliott, an advocate for breast implant illness and implant-related cancer in Canada, noted to CBC News that some symptoms reported by individuals with implants overlap with those of MS.

“Chronic fatigue, memory issues, concentration difficulties, numbness, tingling sensations, nerve pain, muscle weakness, and hair loss — these are all symptoms similar to those of MS,” Elliott remarked.

However, she cautioned against hastily concluding that Applegate’s implants are to blame. “I’m not implying that Christina Applegate’s breast implants are the cause of her symptoms,” she clarified, stating that assuming this would be “premature and irresponsible.”

“Similar symptoms do not automatically equate to the same diagnosis,” Elliott emphasized. “Every possibility should be thoroughly evaluated without being dismissed or ruled out.”

A woman in a large black dress and carrying a black cane, poses on a red carpet.

Christina Applegate, left, attends the 29th Screen Actors Guild Awards in Century City, California, on February 26, 2023. (Valerie Macon/AFP/Getty Images)

Dr. Stephen Nicolaidis, a plastic surgeon based in Montreal, who has treated over 1,500 patients for implant removal, also stressed the importance of exploring other potential causes.

He referred to BII as a “diagnosis of exclusion,” meaning patients must undergo comprehensive evaluations, and if no other causes are identified, the possibility that implants might be contributing to the issues should be considered.

Common symptoms he encounters include fatigue, hair loss, skin rashes, respiratory difficulties, joint and muscle pain, sleep disturbances, and cognitive fog. Some of these overlap with symptoms linked to autoimmune disorders.

Addressing Applegate’s symptoms, he stated, “The symptoms she has described could certainly be related to her breast implants.” Nonetheless, the underlying cause of BII is not well-defined, and he mentioned that researchers do not have clear answers about how implants might lead to such symptoms.

There is no specific test available to diagnose BII, Nicolaidis noted. While imaging might reveal silicone leakage from an implant, he clarified that such findings are not necessary for patients to report their symptoms. He also highlighted that BII differs from implant-associated lymphoma, a type of cancer connected to certain textured implants.

Rupture, Removal, and Next Steps

Ruptures or leaks are distinct concerns separate from BII. The FDA identifies rupture and deflation as potential complications of implants and recommends that patients consult a healthcare provider regarding any new or unusual changes in their breasts.

Likewise, Health Canada advises individuals with implants to routinely check for any unusual breast changes and discuss any signs or symptoms with their physician. Decisions regarding whether to keep, replace, or remove implants should involve consultations with a clinician, considering individual symptoms, potential causes, and surgical risks.

They do not recommend preventative removal of implants due to the associated surgical risks and suggest that individuals with symptoms should address these concerns with a healthcare professional.

Nicolaidis recommended that individuals with symptoms pursue a comprehensive medical assessment. If no other explanations are found, they can discuss the potential contribution of their implants and explore options with their healthcare providers.

He ceased performing breast implant procedures in 2021 due to concerns that their risks overshadow the benefits in numerous cases and has since focused primarily on implant removals. He also noted that removal does not guarantee a resolution of symptoms, as some patients he has treated with MS reported only minor improvements. Those diagnosed with autoimmune conditions may still require ongoing medical treatment after undergoing explant surgery.

Elliott expressed that symptoms linked to implants deserve serious consideration, while acknowledging the lack of comprehensive understanding of their origins. She encouraged patients to seek accurate, evidence-based information and monitor their health changes closely.

“The absence of complete answers should not lead to the dismissal of women’s experiences,” she stated.

Read more

Local News